Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FL1Y2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,358
Award facts
- Contract value 100% obligated
- $17,357.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,357.75 to DMS Pharmaceutical Group Inc. for the supply of 68 milligram Nexplanon implants. The contract, issued on September 9, 2025, with a completion date of September 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order falls under the company's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products.
Nexplanon is a subdermal contraceptive implant used in military and federal healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, maintaining a robust portfolio of delivery orders for medications and medical supplies to Department of Defense healthcare sites nationwide. The company's consistent success in securing contracts without specific set-aside designations demonstrates its competitive positioning in federal procurement, leveraging its woman-owned small business status to support the Defense Logistics Agency's pharmaceutical distribution requirements to military health facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FL1Y2?
SPE2DB25FL1Y2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FL1Y2 worth?
The government has obligated $17,358 on SPE2DB25FL1Y2.
Is contract SPE2DB25FL1Y2 an order under another contract?
Yes. SPE2DB25FL1Y2 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1Y2 competed?
The extent of competition for SPE2DB25FL1Y2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award